borderline significancep = 0.126
Having any glucose measurement ≥130 mg/dL during chemoradiotherapy was associated with inferior outcomes, reaching borderline significance for locoregional control (adjusted HR 1.636, p = 0.126) and overall survival (adjusted HR 1.476, p = 0.130).